LQDA Liquidia Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: LQDA

Price (delayed)

$67.49

Market cap

$6.04B

P/E Ratio

42.99

Dividend/share

N/A

EPS

$1.57

Enterprise value

$5.94B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 99

Liquidia Corporation operates through the company’s subsidiaries, Liquidia Technologies, Inc. and RareGen. The Company, through Liquidia Technologies, Inc., is a late-stage clinical biopharmaceutical company focused on the development and commercialization ...

Highlights
LQDA's net income has soared by 193% YoY
Liquidia's EPS has surged by 187% YoY
The quick ratio is down by 12% YoY but it is up by 4% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.liquidia.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of LQDA

LQDA stock price

How has the Liquidia stock price performed over time
Intraday
-1.68%
1 week
-1.4%
1 month
-1.65%
1 year
200.62%
YTD
95.68%
QTD
-15.35%

Financial performance

How have Liquidia's revenue and profit performed over time
Revenue
$450.91M
Gross profit
$417.28M
Operating income
$168.58M
Net income
$138.61M
Gross margin
92.5%
Net margin
30.7%
LQDA's net income has soared by 193% YoY
The company's operating margin has surged by 137% QoQ and by 105% YoY
The company's net margin has surged by 104% YoY
LQDA's gross profit has surged by 58% since the previous quarter

Price vs fundamentals

How does LQDA's price correlate with its fundamentals

Growth

What is Liquidia's growth rate over time

Valuation

What is Liquidia stock price valuation
P/E
42.99
P/B
30.76
P/S
13.3
EV/EBIT
33.7
EV/EBITDA
33.38
EV/Sales
13.16
Liquidia's EPS has surged by 187% YoY
LQDA's equity has surged by 80% since the previous quarter
The stock's P/B is 46% above its 5-year quarterly average of 21.4 but 44% below its last 4 quarters average of 55.7
The stock's price to sales (P/S) is 62% less than its 5-year quarterly average of 35.9 and 27% less than its last 4 quarters average of 18.6
LQDA's revenue has soared by 57% QoQ

Efficiency

How efficient is Liquidia business performance
The ROIC has soared by 196% YoY
The ROE has soared by 164% YoY
The ROA has soared by 159% YoY
Liquidia's return on sales has surged by 116% QoQ and by 106% YoY

Dividends

What is LQDA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LQDA.

Financial health

How did Liquidia financials performed over time
The total assets is 60% more than the total liabilities
The total assets has soared by 103% YoY and by 30% from the previous quarter
The company's total liabilities rose by 35% YoY and by 12% QoQ
The company's debt is 6% lower than its equity
The debt to equity has plunged by 93% YoY and by 45% from the previous quarter
LQDA's equity has surged by 80% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.